Polycationic macromolecules and cationic peptides acting as PTDs (protein transduction domains) and CPPs (cell-penetrating peptides) represent important classes of agents used for the import and delivery of a wide range of molecular cargoes into cells. Their entry into cells is typically initiated through interaction with cell-surface HS (heparan sulfate) molecules via electrostatic interactions, followed by endocytosis of the resulting complexes. However, the endocytic mechanism employed (clathrin-mediated endocytosis, caveolar uptake or macropinocytosis), defining the migration of these peptides into cells, depends on parameters such as the nature of the cationic agent itself and complex formation with cargo, as well as the nature and distribution of proteoglycans expressed on the cell surface. Moreover, a survey of the literature suggests that endocytic pathways should not be considered as mutually exclusive, as more than one entry mechanism may be operational for a given cationic complex in a particular cell type. Specifically, the observed import may best be explained by the distribution and uptake of cell-surface HSPGs (heparan sulfate proteoglycans), such as syndecans and glypicans, which have been shown to mediate the uptake of many ligands besides cationic polymers. A brief overview of the roles of HSPGs in ligand internalization is presented, as well as mechanistic hypotheses based on the known properties of these cell-surface markers. The identification and investigation of interactions made by glycosaminoglycans and core proteins of HSPGs with PTDs and cationic polymers will be crucial in defining their uptake by cells.
Introduction
Cationic lipids and polymers, such as PEI (polyethyleneimine), enter cells efficiently and are widely used as transfection agents in delivering plasmids and oligonucleotides into eukaryotic cells [1] [2] [3] . These agents titrate the negative charges on nucleic acids, resulting in condensed cationic complexes that are readily internalized by cells. Short cationic peptides can also act as PTDs (protein transduction domains), also known as CPPs (cell-penetrating peptides), and these peptides can transport drugs, peptides, proteins and oligonucleotides as well as large macromolecules (which can be up to several hundred nanometres in size) into cells [4] [5] [6] [7] . PTDs can also be introduced into recombinant proteins or synthetic peptides, generating biomolecular conjugates with a builtin ability to be internalized by cells. Typically, PTDs are sequences rich in lysine or arginine (R n , where n 8) residues, with some sequences originally derived from basic domains of proteins, such as the HIV-1 Tat (HIV type 1 transactivator of transcription) protein and the Antennapedia homeodomain [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Studies on truncated and alanine-substituted analogues of the HIV-1 Tat peptide (containing the core Key words: cell-penetrating peptide (CPP), drug delivery, glypican, heparan sulfate proteoglycan (HSPG), protein transduction domain (PTD), syndecan. Abbreviations used: CPP, cell-penetrating peptide; dyn, dynamin; GPI, glycosylphosphatidylinositol; HIV-1 Tat, HIV type 1 transactivator of transcription; HS, heparan sulfate; HSPG, heparan sulfate proteoglycan; LDL, low-density lipoprotein; LPL, lipoprotein lipase; PEI, polyethyleneimine; PTD, protein transduction domain; Tf, transferrin. 1 To whom correspondence should be addressed (email gariepy@uhnres.utoronto.ca).
sequence RKKRRQRRR [18] ), as well as cationic homooligomers, have highlighted the importance of charge density and arginine residues on the transduction potential of PTDs [19] [20] [21] .
Research on the import mechanism of cationic peptides into cells remains an area of intense investigation (reviewed in [1, 18, 22] ). With some exceptions [23] , interactions with cell-surface HS (heparan sulfate) ( Figure 1 ) are required for the internalization of PTDs [6, [24] [25] [26] [27] [28] [29] , as well as for other cationic molecules such as PEI [30] and endogenous polyamines, e.g. putrescine, spermidine and spermine [31] . Specifically, treatment with heparin (a highly sulfated form of HS) or the action of heparinases has been shown to inhibit PTD uptake by cells, while cell lines deficient in the synthesis of cell-surface HS or any glycosaminoglycan (GAG), such as CHO (Chinese-hamster ovary) pgsD-677 and pgsD-A475 respectively, do not import cationic peptides [32] [33] [34] . While there is general agreement that binding to HS is an obligate first step in an energy-dependent endocytic pathway, the actual mechanism of transduction remains controversial. The uptake of PTDs and other cationic polymers has previously been reported to occur at sub-physiological temperatures or in the absence of cellular ATP (by pre-treatment with azide or deoxyglucose) [13, 17, 25] . However, this mode of cellular entry was subsequently attributed to be an artefact of cell fixation prior to microscopy, or failure to remove membrane-bound ligand prior to FACS analysis [24, [35] [36] [37] . Nonetheless, the possibility of an energy-independent entry mechanism into cells for very short cationic peptides cannot [86] . They are elongated by disaccharide blocks consisting of [63, 66] extending from the linker. Subsequently, carbohydrate moieties are extensively modified (shown in bold) by deacetylation, sulfation and epimerization in the Golgi apparatus [87] ; several of these modified disaccharides are shown.
be excluded, and some workers continue to report HS-, temperature-and energy-independent transduction of PTDs, albeit usually as a quantitively minor transport pathway [23, 38, 39] .
This review focuses on the current theories relating to the more common import pathways of PTD and cationic agents into cells, typically involving sequestration into vesicular compartments. In this regard, a lack of consensus exists, with clathrin-dependent endocytosis [6, 40] , as well as clathrinindependent mechanisms, including caveolar endocytosis [5, 41, 42] and macropinocytosis [9, 10, 21, 28, [43] [44] [45] , being heralded as dominant mechanisms of PTD internalization ( Table 1) .
Endocytosis of PTDs and cationic agents:
does it involve clathrin-coated pits, caveolae, macropinocytosis or a combination of pathways?
Endocytosis is an umbrella term for a diverse collection of energy-dependent internalization phenomena that can be broadly divided into phagocytic and pinocytic pathways that include clathrin-dependent internalization and clathrinindependent processes involving lipid rafts. These pathways have been extensively reviewed elsewhere [46] [47] [48] . Phagocytosis is restricted to functionally specialized cells such as macrophages, monocytes and neutrophils. Clathrinmediated endocytosis, the best-studied endocytic pathway, involves sequestration of high-affinity transmembrane receptors and their bound ligands into coated pits on the plasma membrane, which pinch off to form endosomes [49] . Classical markers for clathrin-mediated endocytosis, which include receptors for LDL (low-density lipoprotein), Tf (transferrin) and α 2 -macroglobulin, are frequently used to demonstrate this pathway in co-localization experiments.
Clathrin-independent endocytosis (excluding phagocytosis) involves at least two major import mechanisms that are not well-characterized at the molecular level, namely caveolin-mediated endocytosis and macropinocytosis [46] . One feature of caveolar endocytosis is the involvement of lipid rafts. These are detergent-resistant microdomains (∼50 nm in size) in the plasma membrane that accumulate glycosphingolipids, sphingomyelin, cholesterol and GPI (glycosylphosphatidylinositol)-anchored proteins [50, 51] . Caveolae Table 1 Summary of mechanisms reported for the endocytosis of PTDs This summary does not include reports in which an actual import mechanism was not demonstrated [23, 24, 26, 27, 29] or where results were confounded by cell fixation prior to analysis [8] . Macropinocytosis was also recently challenged by other studies [38] , showing that the import of 125 I-YGR 9 
Mechanism PTD/cargo Cells analysed Evidence provided
Clathrin-dependent FAM-10R/10K/Tat-p53tet [6] CHO [6, 40] Jurkat T-cells, Lack of inhibition by nystatin [6] and filipin [40] endocytosis Tat-FITC [40] HeLa, HepG2 [40] Inhibition by MDC [6] , cytochalasin D [6] , CPZ [40] Inhibition in hypertonic [6] and K + -free media [40] Caveolar endocytosis Tat-phage D protein [5] VA13/2RA, 293, NIH-3T3, Slower kinetics compared with coated pits [41, 42] GST-Tat protein-EGFP [41, 42] A431 [5] Co-localization with 10 kDa dextran, CTB and COS-1 [5, 42] caveolin-1 [42] HeLa [5, 41, 42] Lack of co-localization with Tf and Lysotracker TM [42] Jurkat T-cells [42] Inhibition by filipin [5] FITC-/Cy5-β 2 macroglobulin/NeuroD islet/duct cells [9] Inhibition by amiloride [9, 10, 28, 45] , EIPA [21, 43] , protein [9] cytochalasin D [9, 21, 28, 45] , nystatin [28, 45] , MβCD [21, 28] constitute a specialized form of lipid raft in which the marker protein caveolin is variably enriched [52] . In the case of macropinocytosis, actin-driven ruffling membrane protrusions called lamellipodia scoop up relatively large volumes of extracellular fluid and fuse onto the plasma membrane to form large irregular vesicles, known as macropinosomes [47] . A common criterion used to differentiate macropinocytosis from caveolar and clathrin-dependent endocytosis is the lack of dependence of macropinocytosis on the GTPase dyn (dynamin), demonstrated by expression of the dominantnegative mutant dyn K44A (Table 1 ) [53] . The lack of consensus on the endocytic pathways used by cationic polymers, particularly PTDs (Table 1) , is partially attributable to the ambiguity inherent in the current characterization of these pathways. Although some endocytic mechanisms are distinguishable morphologically, and may be associated with characteristic structural proteins (e.g. clathrin and caveolin), biochemical and pharmacological probes of these pathways can be ambiguous. For example, a lack of dependence on dyn, a purported biochemical hallmark of macropinocytosis, has also been reported for GPI-linked proteins that appear to accumulate in caveosomes and clathrin-coated endosomes [54, 55] . Equally contentious is the use of drugs that deplete cholesterol from lipid rafts. Specifically, caveolin is observed to concentrate in cholesterol-enriched lipid rafts, and many studies infer that inhibition of cellular uptake by such drugs is evidence for caveolar endocytosis [5, 41, 42] . However, cholesterol depletion has also been shown to perturb macropinocytosis [21, 28] as well as clathrindependent endocytosis [56] [57] [58] . Thus lipid rafts appear to participate in multiple endocytic pathways, possibly in a signalling capacity [59] , even though some uptake markers (such as LDL and Tf, in the case of clathrin-dependent endocytosis) may be excluded from them. Given the current limits of our knowledge of the molecular mechanisms of endocytosis, particularly with respect to the role of lipid rafts [51] , a more coherent view would be that import pathways possess characteristics which are also associated with any number of known cellular mechanisms [60] . Moreover, these pathways need not be mutually exclusive, but instead may dynamically compete for ligands, as has been demonstrated for transforming growth factor-β (TGFβ) [61] , viruses [62] and bacterial toxins [48] . In the case of PTDs, the uptake of NLS (nuclear localization sequence)-R 10 (tetrameric scaffold Figure 2 Schematic organization of HSPGs and endocytic markers on the plasma membrane Syndecans (transmembrane) and glypicans (extrinsic, GPI-linked) are the two primary classes of HSPG found on the apical cell surface. Glypicans are preferentially associated with lipid rafts (detergent-resistant microdomains enriched in relatively saturated phospholipids, glycosphingolipids and cholesterol). In caveolae, which are specialized forms of lipid rafts, caveolin (shown here as non-covalently associated oligomers) participates in the formation of vesicles (caveosomes). Clathrin, bound to an assembly protein (AP) and a given transmembrane receptor, is generally excluded from lipid rafts. Upon binding of cationic polymers (shown attached to a generic cargo) to cell-surface HSPGs, endocytic pathways (clathrin-dependent, caveolar and/or macropinocytosis) are activated resulting in the sequestration of the cargo into vesicles (not shown). The molecular details of these activation events remain to be elucidated, but probably require protein-protein interactions involving clathrin, caveolin, macropinocytic proteins and the core proteins of HSPGs (including the cytoplasmic domain of syndecans which may also function in a signalling capacity). ECM, extracellular matrix.
of the p53 tetramerization domain) through clathrin-coated pits is enhanced after treatment with nystatin, suggesting the removal of a presumably less efficient raft-mediated pathway [6] . Another example is the endocytic uptake of R 8 -labelled liposomes, which switches from a primarily clathrindependent pathway at a low peptide density (0.9 mol% stearyl-R 8 ), to a primarily macropinocytic path at higher peptide densities (5.2 mol%) [45] . It may be that endocytic pathways operate in an interactive and compensatory fashion.
A step forward: the role of cell-surface heparan proteoglycans as portals guiding endocytosis of PTDs
While much attention has focused on the requirement for cellsurface HS in the internalization of PTDs and the physicochemical determinants of HS-ligand interactions [18, 19, 21] , the role of the core proteins to which these HS chains are attached has been largely ignored until very recently [43] . This lack of knowledge regarding the downstream interactions made by HSPGs (heparan sulfate proteoglycans), and by the core proteins in particular, has contributed to the current ambiguity in the understanding of endocytic uptake of PTDs and cationic transfection agents. The presentation of HS on the cell surface is highly regulated, and is primarily linked with specific core proteins via a GlcA-Gal-Gal-XylSer linkage, giving rise to syndecans or glypicans (Figures 1  and 2 ) [63] . In polarized cells, the basolateral membrane HS is also associated with the specialized core proteins perlecan, agrin and type XVIII collagen [64, 65] (HSPGs are reviewed in [65, 66] ). The core proteins of syndecans are type I transmembrane proteins that characteristically harbour HS chains in their ectodomains at two or three canonical Ser-Gly O-glycosylation sites near the N-terminus. There are four known mammalian syndecans, with syndecan-1 and -3 representing a subfamily that also presents chondroitin sulfate chains near the plasma membrane [67] . The cytoplasmic domains of syndecans interact with a number of proteins, including actin-binding proteins and F-actin. These interactions can be regulated by phosphorylation of an invariant serine residue and three invariant tyrosine residues (Figure 2 ) [66] .
In contrast with syndecans, glypicans are extrinsic membrane proteins that are GPI-anchored to the plasma membrane, and HS chains are attached at two or three SerGly sites proximal to the plasma membrane [68] . The core domain of glypicans contains 14 highly conserved cysteine residues, which suggests a disulfide-linked, possibly globular, conformation (Figure 2 ). There are at least six glypican genes in mammals [69] , and, as is the case for many other GPIanchored proteins, glypicans are associated with lipid rafts [66] .
Syndecans and glypicans exhibit tissue-and developmentally specific expression in vivo and are associated with a myriad of receptor functions that lead to activation of signal transduction pathways or internalization of ligands (reviewed in [70] ). A huge array of ligands (including PTDs) are known to bind cell-surface HSPGs [66] , but the identity of the HSPGs involved and the mechanism by which they stimulate endocytosis are, for most cases, unknown. Exceptions include FGF2 (fibroblast growth factor 2), which depends on syndecan-4 for its uptake by macropinocytosis [71] and the endocytic clearance of various lipoproteins. While the HS-independent internalization of LDL receptorbound lipoproteins via clathrin-coated pits is well known, alternative HSPG-dependent endocytic pathways are being described [72] . Syndecans [73] and perlecan [74] have been shown to mediate the clathrin-independent endocytosis of unmodified lipoproteins and apoE (apolipoprotein E)-VLDL (very-low-density lipoprotein) bound to LPL (lipoprotein lipase), which occurs through the interaction of LPL with HSPGs and results in the lysosomal degradation of lipoproteins.
Given the critical requirement for cell-surface HS for endocytosis of PTDs and cationic agents, regardless of the observed mechanisms of internalization, a role for HSPGs is very likely. A physiological role for glypican-1 in the cellular homoeostasis of polyamines has been demonstrated previously [75] . Specifically, the inhibition of polyamine biosynthesis resulted in up-regulation of exogenous import by a complex mechanism that promoted the liberation of tightly HS-bound polyamines in recycling glypican-1 caveosomes [76] . Although the involvement of HSPGs has been suggested periodically [42] and implicated indirectly [29] , there has been no attempt to identify them directly until recently [43] . Nonetheless, a number of reasonable hypotheses present themselves. Syndecans, owing to their association with actin microfilaments, which are crucial for uptake, may have a direct role in the formation of endocytic vesicles [30] . This situation may be particularly prevalent in the case of syndecan-4, which is ubiquitously present on the surface of adherent cells [66] . It has also been suggested that the distal position of attached HS chains in the ectodomains of syndecans facilitates their interaction with bulky cargoes (Figure 2) [30, 73] . Glypican-1 is ubiquitously expressed in all adult tissues [66] , and, despite possessing proximal HS chains and lacking cytoplasmic domains, a role for glypicans should not be excluded. They may interact with other cell-surface proteins that can activate endocytosis, which may be induced through ligand-glypican interaction. This is a reasonable proposition, given the pervasive association of GPI-anchored proteins (such as glypicans) with lipid rafts such as caveolae [50, 66] , although raft-associated syndecans have also been reported [77, 78] .
Thus HSPGs represent the intermediates that may explain the divergent yet compensatory mechanisms observed for endocytosis of PTDs. The attached HS chains bind ligands, whereas regions within the core protein may recruit specific interacting partners that activate a particular endocytic pathway. In this hypothesis, activation of seemingly unrelated endocytic pathways becomes a logical consequence of differential HSPG-mediated interactions upon ligand binding to the HS chains. In this respect, syndecans are known to oligomerize [66] , and efficient endocytosis is enhanced by ligandinduced clustering of syndecans [73] , which suggests a mechanism for the marked enhancement in endocytosis caused by the multivalent presentation of ligands [6, 79] . Ligandinduced clustering may also provide a means for conferring selectivity for competing pathways [43, 45] , even though the interactions of PTDs and cationic agents with HS are relatively non-specific [80] . It is also interesting to speculate on the effects of adaptation in the HSPGs themselves, in response to the physiological needs of the cell for ligand internalization. For example, the amount and size of HS chains present on syndecans varies depending on the different stages of cellular differentiation [81, 82] or, for polarized epithelial cells, their extracellular context (cell-cell and cell-matrix interactions) [83] . Such considerations may be important when PTDs and cationic molecules are used in vivo.
Since the intracellular routing of vesicles formed from the various endocytic pathways can be quite different [48] , understanding the mechanistic basis of endocytic route selectivity is also relevant in terms of their cellular disposition, specifically the extent to which endosomal contents become entrapped and degraded in lysosomes and/or effluxed as part of membrane recycling events [84] . Although endocytosed PTDs can be observed distributed in the cytosol and specific subcellular compartments, such as the nucleus, the vast majority of internalized polycations and their cargoes (>90%) remains entrapped in endosomes, degraded [85] or shuttled out of the cell [6, 28, 40, 45] . To date, efforts to overcome endosomal entrapment have focused on various endosomolytic strategies. An understanding of the molecular mechanisms of PTD endocytosis may also provide solutions to manipulate endosomal trafficking and reduce, or possibly avoid altogether, endosomal entrapment. 
